Swift Pace Of Accelerated Approval Submissions Suggests Strong Constituency For US FDA Program

FDA may be evaluating the future of accelerated approval, but data from the Pink Sheet’s Performance Tracker shows growth in the submissions and approvals over the past five years.

Gears growth (Cherries/Shuttertock.com)

More than 25 years after the US Food and Drug Administration established accelerated approval, the pathway is more popular than ever, with 2020 starting off at a potentially record-setting pace.

Of the new drug and biologic applications and efficacy supplements approved by FDA this year, more than 14% received accelerated...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Review Pathways

More from Pathways & Standards